Loading…
Depression in Parkinson's disease : biogenic amines in CSF of de novo patients
Etiology of depression in Parkinson's disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of...
Saved in:
Published in: | Journal of Neural Transmission 1996-01, Vol.103 (12), p.1441-1445 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593 |
---|---|
cites | cdi_FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593 |
container_end_page | 1445 |
container_issue | 12 |
container_start_page | 1441 |
container_title | Journal of Neural Transmission |
container_volume | 103 |
creator | KUHN, W MÜLLER, T GERLACH, M SOFIC, E FUCHS, G HEYE, N PRAUTSCH, R PRZUNTEK, H |
description | Etiology of depression in Parkinson's disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated "de novo" Parkinsonian patients.
Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score > or = 18 and HD score < 18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.
In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.
In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD. |
doi_str_mv | 10.1007/BF01271258 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78685810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16411557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593</originalsourceid><addsrcrecordid>eNqFkc1Lw0AQxRdRav24eBf2IApCdCfZ3Wy8abUqiArqOUySqay2uzXTCv73prTUo6dheD_eg_eEOAB1Bkrl51dDBWkOqXEbog86Mwlom22KvsqUSgpj9bbYYf5QSgHkrid6hUoLDdAXj9c0bYnZxyB9kM_YfvrAMZywbDwTMskLWfn4TsHXEic-EC_AwctQxpFsSIb4HeUUZ57CjPfE1gjHTPuruyvehjevg7vk4en2fnD5kNQa9Cxp0FjQZGxR26ZBB1lRZbmmCitojFXGoeleXTUagVJlMTU2J20QK0umyHbF8dJ32savOfGsnHiuaTzGQHHOZe6sMw7UvyDYrgZj8v_BLjUvikX06RKs28jc0qictn6C7U8JqlzMUf7N0cGHK9d5NaFmja767_SjlY5c43jUYqg9r7HUpFY7l_0Cpx2PPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15937999</pqid></control><display><type>article</type><title>Depression in Parkinson's disease : biogenic amines in CSF of de novo patients</title><source>Springer LINK Archives</source><creator>KUHN, W ; MÜLLER, T ; GERLACH, M ; SOFIC, E ; FUCHS, G ; HEYE, N ; PRAUTSCH, R ; PRZUNTEK, H</creator><creatorcontrib>KUHN, W ; MÜLLER, T ; GERLACH, M ; SOFIC, E ; FUCHS, G ; HEYE, N ; PRAUTSCH, R ; PRZUNTEK, H</creatorcontrib><description>Etiology of depression in Parkinson's disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated "de novo" Parkinsonian patients.
Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score > or = 18 and HD score < 18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.
In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.
In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.</description><identifier>ISSN: 0300-9564</identifier><identifier>EISSN: 1435-1463</identifier><identifier>DOI: 10.1007/BF01271258</identifier><identifier>PMID: 9029411</identifier><identifier>CODEN: JNTMAH</identifier><language>eng</language><publisher>Wien: Springer</publisher><subject>Aged ; Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Depression - cerebrospinal fluid ; Depression - etiology ; Dopamine - cerebrospinal fluid ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Neurology ; Norepinephrine - cerebrospinal fluid ; Parkinson Disease - cerebrospinal fluid ; Parkinson Disease - psychology ; Serotonin - cerebrospinal fluid</subject><ispartof>Journal of Neural Transmission, 1996-01, Vol.103 (12), p.1441-1445</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593</citedby><cites>FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2526488$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9029411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KUHN, W</creatorcontrib><creatorcontrib>MÜLLER, T</creatorcontrib><creatorcontrib>GERLACH, M</creatorcontrib><creatorcontrib>SOFIC, E</creatorcontrib><creatorcontrib>FUCHS, G</creatorcontrib><creatorcontrib>HEYE, N</creatorcontrib><creatorcontrib>PRAUTSCH, R</creatorcontrib><creatorcontrib>PRZUNTEK, H</creatorcontrib><title>Depression in Parkinson's disease : biogenic amines in CSF of de novo patients</title><title>Journal of Neural Transmission</title><addtitle>J Neural Transm (Vienna)</addtitle><description>Etiology of depression in Parkinson's disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated "de novo" Parkinsonian patients.
Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score > or = 18 and HD score < 18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.
In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.
In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Depression - cerebrospinal fluid</subject><subject>Depression - etiology</subject><subject>Dopamine - cerebrospinal fluid</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Norepinephrine - cerebrospinal fluid</subject><subject>Parkinson Disease - cerebrospinal fluid</subject><subject>Parkinson Disease - psychology</subject><subject>Serotonin - cerebrospinal fluid</subject><issn>0300-9564</issn><issn>1435-1463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkc1Lw0AQxRdRav24eBf2IApCdCfZ3Wy8abUqiArqOUySqay2uzXTCv73prTUo6dheD_eg_eEOAB1Bkrl51dDBWkOqXEbog86Mwlom22KvsqUSgpj9bbYYf5QSgHkrid6hUoLDdAXj9c0bYnZxyB9kM_YfvrAMZywbDwTMskLWfn4TsHXEic-EC_AwctQxpFsSIb4HeUUZ57CjPfE1gjHTPuruyvehjevg7vk4en2fnD5kNQa9Cxp0FjQZGxR26ZBB1lRZbmmCitojFXGoeleXTUagVJlMTU2J20QK0umyHbF8dJ32savOfGsnHiuaTzGQHHOZe6sMw7UvyDYrgZj8v_BLjUvikX06RKs28jc0qictn6C7U8JqlzMUf7N0cGHK9d5NaFmja767_SjlY5c43jUYqg9r7HUpFY7l_0Cpx2PPw</recordid><startdate>19960101</startdate><enddate>19960101</enddate><creator>KUHN, W</creator><creator>MÜLLER, T</creator><creator>GERLACH, M</creator><creator>SOFIC, E</creator><creator>FUCHS, G</creator><creator>HEYE, N</creator><creator>PRAUTSCH, R</creator><creator>PRZUNTEK, H</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19960101</creationdate><title>Depression in Parkinson's disease : biogenic amines in CSF of de novo patients</title><author>KUHN, W ; MÜLLER, T ; GERLACH, M ; SOFIC, E ; FUCHS, G ; HEYE, N ; PRAUTSCH, R ; PRZUNTEK, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Depression - cerebrospinal fluid</topic><topic>Depression - etiology</topic><topic>Dopamine - cerebrospinal fluid</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Norepinephrine - cerebrospinal fluid</topic><topic>Parkinson Disease - cerebrospinal fluid</topic><topic>Parkinson Disease - psychology</topic><topic>Serotonin - cerebrospinal fluid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KUHN, W</creatorcontrib><creatorcontrib>MÜLLER, T</creatorcontrib><creatorcontrib>GERLACH, M</creatorcontrib><creatorcontrib>SOFIC, E</creatorcontrib><creatorcontrib>FUCHS, G</creatorcontrib><creatorcontrib>HEYE, N</creatorcontrib><creatorcontrib>PRAUTSCH, R</creatorcontrib><creatorcontrib>PRZUNTEK, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Neural Transmission</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KUHN, W</au><au>MÜLLER, T</au><au>GERLACH, M</au><au>SOFIC, E</au><au>FUCHS, G</au><au>HEYE, N</au><au>PRAUTSCH, R</au><au>PRZUNTEK, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depression in Parkinson's disease : biogenic amines in CSF of de novo patients</atitle><jtitle>Journal of Neural Transmission</jtitle><addtitle>J Neural Transm (Vienna)</addtitle><date>1996-01-01</date><risdate>1996</risdate><volume>103</volume><issue>12</issue><spage>1441</spage><epage>1445</epage><pages>1441-1445</pages><issn>0300-9564</issn><eissn>1435-1463</eissn><coden>JNTMAH</coden><abstract>Etiology of depression in Parkinson's disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated "de novo" Parkinsonian patients.
Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score > or = 18 and HD score < 18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.
In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.
In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.</abstract><cop>Wien</cop><cop>New York, NY</cop><pub>Springer</pub><pmid>9029411</pmid><doi>10.1007/BF01271258</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-9564 |
ispartof | Journal of Neural Transmission, 1996-01, Vol.103 (12), p.1441-1445 |
issn | 0300-9564 1435-1463 |
language | eng |
recordid | cdi_proquest_miscellaneous_78685810 |
source | Springer LINK Archives |
subjects | Aged Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depression - cerebrospinal fluid Depression - etiology Dopamine - cerebrospinal fluid Female Humans Male Medical sciences Middle Aged Neurology Norepinephrine - cerebrospinal fluid Parkinson Disease - cerebrospinal fluid Parkinson Disease - psychology Serotonin - cerebrospinal fluid |
title | Depression in Parkinson's disease : biogenic amines in CSF of de novo patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A36%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depression%20in%20Parkinson's%20disease%20:%20biogenic%20amines%20in%20CSF%20of%20de%20novo%20patients&rft.jtitle=Journal%20of%20Neural%20Transmission&rft.au=KUHN,%20W&rft.date=1996-01-01&rft.volume=103&rft.issue=12&rft.spage=1441&rft.epage=1445&rft.pages=1441-1445&rft.issn=0300-9564&rft.eissn=1435-1463&rft.coden=JNTMAH&rft_id=info:doi/10.1007/BF01271258&rft_dat=%3Cproquest_cross%3E16411557%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c414t-da5614e569c6dda8139b374ebab1d56058a574e4bd4a1e206a2567e45aab6e593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15937999&rft_id=info:pmid/9029411&rfr_iscdi=true |